Relationship Between Fertility Hormone Patterns and Pregnancy Rates.

Pregnancy Related Clinical Trial

Official title:

Relationship Between Fertility Hormone Patterns and Pregnancy Rates.

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05033366
• Other study ID #: 2021/03/29
• Status: Enrolling by invitation
• Start date: March 1, 2020
• Est. completion date: April 2026

Study information

• Verified date: March 2024
• Source: MFB Fertility
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to determine if certain patterns of hormone levels during the menstrual cycle are correlated with different pregnancy outcomes.

Description:

Proov tests are fertility tracking tests. They are used for monitoring ovulation at home, and are able to measure one or more hormones. These hormones can predict and confirm ovulation. Tracking these hormones can help a woman understand if she is ovulating, and can help to identify problems that could be preventing pregnancy.

After giving permission to access your testing history collected in the Proov app from March 2020 to April 2022, you will complete an online survey about your fertility test results and pregnancy status. You will also be asked information regarding your age, race, smoking status, and BMI. Your test results logged in the Proov app will be shared automatically. You will need 10-20 minutes to fill out the fertility survey.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 5000
• Est. completion date: April 2026
• Est. primary completion date: April 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Female

2. Age 18 - no limit

3. Have completed one full cycle using the Proov app

Exclusion Criteria:

1. Male

2. Have not completed one full cycle using the Proov app

Related Conditions & MeSH terms

• Hormone Deficiency
• Pregnancy Related

Intervention

Diagnostic Test:
• Proov Test
Rapid response urine PdG, FSH, E1G and LH test strips, Proov

Locations

Country	Name	City	State
United States	MFB Fertility	Boulder	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
MFB Fertility

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	self reported pregnancy	Questionnaire used to assess if positive Proov test strips measuring urine PDG correlate with increased rates of self reported pregnancy	Two menstrual cycle, up to 45 days each
Secondary	self reported first trimester pregnancy loss	Questionnaire used to assess if negative Proov test strips measuring urine PDG correlate with increased rates of self reported first trimester pregnancy loss	Three months